We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Study Probes Role of Sestrin 3 in Glucose Metabolism and Diabetes Development

By LabMedica International staff writers
Posted on 18 Nov 2014
Print article
Image: The Sestrin 3 protein, labeled in red fluorescence and shown interacting with other proteins (highlighted in yellow) in the liver, may have implications in treating type II diabetes (Photo courtesy of the Indiana University School of Medicine).
Image: The Sestrin 3 protein, labeled in red fluorescence and shown interacting with other proteins (highlighted in yellow) in the liver, may have implications in treating type II diabetes (Photo courtesy of the Indiana University School of Medicine).
A recent paper discussed the role of sestrin proteins in resisting oxidative stress and regulating metabolic processes such as glucose production and insulin sensitivity, which are disrupted in type II diabetes and metabolic syndrome.

Investigators at Indiana University School of Medicine (Indianapolis, USA) focused their attention on the protein Sestrin 3 (Sesn3). The gene for this protein in humans is located on chromosome 11q21. The sestrin family of proteins, of which Sesn3 is a member, comprises cysteine sulfinyl reductases, and they modulate peroxide signaling and antioxidant defense. These proteins selectively reduce or repair hyperoxidized forms of typical 2-cysteine peroxiredoxins (enzymes that metabolize peroxides) in eukaryotes.

Sestrin expression was found to be regulated by the tumor suppressor protein p53. Sesn3 was identified as a forkhead box O (FoxO) protein with antioxidant activity. Recently it was reported that Sesn3 may play an important role in Akt induced increase in reactive oxygen species (ROS), and it might be a promising target in selectively killing cancer cells containing high levels of Akt activity.

Akt, also known as protein kinase B (PKB), is a serine/threonine-specific protein kinase that plays a key role in multiple cellular processes such as glucose metabolism, apoptosis, cell proliferation, transcription, and cell migration. Akt is hyperactivated in cancer. This hyperactivity leads to an increase in intracellular ROS mainly by inhibiting the expression of ROS scavengers downstream of FoxO, such as Sesn3.

In the current study, the investigators generated Sesn3 liver-specific transgenic and knockout mice. These animals were fed a diet with 18% of its calories from fat or a high-fat diet with 60% of calories from fat.

Results published in the November 5, 2014, online edition of the journal Diabetes revealed that mice lacking Sesn3 had elevated fasting blood glucose levels, indicative of impaired liver insulin sensitivity or poorly regulated glucose metabolism. Insulin and glucose tolerance tests were significantly improved in Sesn3-positive control mice.

Biochemical analysis revealed that Sesn3 interacted with and activated mTORC2 (mechanistic target of rapamycin complex 2) and subsequently stimulated Akt phosphorylation at serine 473. These findings suggested that Sesn3 could activate Akt via mTORC2 to regulate liver insulin sensitivity and glucose metabolism.

Senior author Dr. X. Charlie Dong, associate professor of biochemistry and molecular biology at the Indiana University School of Medicine, said, "We wanted to show that Sestrin 3 had critical liver-specific functions. This is a very fascinating protein. It is not very big, but it functions in a very dynamic manner controlling glucose production and insulin sensitivity. It is an important regulator for glucose homeostasis."

Related Links:

Indiana University School of Medicine


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.